Immunotherapy has emerged as a revolutionary approach to cancer treatment, leveraging the body's immune system to combat malignancy. This article provides a comprehensive overview of immunotherapy, its mechanisms, and clinical applications, offering physicians an essential guide to this groundbreaking field.
Immunotherapy, also known as biological therapy, involves the use of living organisms, substances derived from them, or laboratory-produced versions of such substances to enhance or restore immune system function. It can either stimulate the immune system to work harder or smarter to attack cancer cells or provide the immune system with components, such as man-made immune system proteins.
Immunotherapy is categorized into several types: Monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, and non-specific immunotherapies. Each type works differently and is used in different cancer types. Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system's attack on cancer cells. Immune checkpoint inhibitors are drugs designed to unleash an immune system attack on cancer cells. Cancer vaccines are substances introduced into the body to cause an immune response against certain diseases. Non-specific immunotherapies generally boost the immune system in a general way, which can still help the immune system attack cancer cells.
Immunotherapy holds a critical position in modern healthcare due to its potential to treat a wide range of cancers. Its advantages include fewer side effects, a more targeted approach, and the potential for a durable response. However, not all patients respond to immunotherapy, and its use can sometimes lead to overactivation of the immune system, causing severe side effects.
Immunotherapy has transformed the landscape of cancer treatment, offering hope where traditional therapies have failed. As our understanding of the immune system and cancer biology continues to grow, so will the potential of immunotherapy. Physicians must stay updated with this rapidly evolving field to provide the best care for their patients.
1.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
2.
Bayer is transforming pharmaceutical research into women's health
3.
Biomarker panel offers hope for early pancreatic cancer detection
4.
A small rise in cancer was observed following the 1986 Chernobyl accident.
5.
Added Plinabulin Boosts OS as Later-Line Treatment for EGFR Wild-Type NSCLC
1.
Beyond the Brain Fog: The Complex Neurological Challenges and Therapeutic Advances
2.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
3.
Immune Microenvironment Biomarkers for Early Tumor Evolution
4.
Transformative Methods in Oncology and Quality Improvement
5.
Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation